• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

根治性胃手术后心脏病或慢性肝病患者发病率增加。

Increased morbidity rates in patients with heart disease or chronic liver disease following radical gastric surgery.

机构信息

Department of Surgery, Seoul National University College of Medicine, Seoul, Korea.

出版信息

J Surg Oncol. 2010 Mar 1;101(3):200-4. doi: 10.1002/jso.21467.

DOI:10.1002/jso.21467
PMID:20063368
Abstract

BACKGROUND

The aim of this study was to investigate possible associations between (i) comorbid disease and (ii) perioperative risk factors and morbidity following radical surgery for gastric cancer.

MATERIALS AND METHODS

Consecutive patients (759) undergoing radical gastrectomy and D2 level lymph node dissection for gastric cancer were included. Clinical data concerning patient characteristics, operative methods, and complications were collected prospectively.

RESULTS

The morbidity rate for radical gastrectomy was 14.2% (108/759). The most significant comorbid risk factors for postoperative morbidity were heart disease [anticoagulant medication: OR = 1.5 (95% CI = 0.35-6.6, P = 0.53); history without medication: OR = 4.0 (95% CI = 1.1-14.6, P = 0.03); history with current medication: OR = 6.7 (95% CI = 1.5-29.9, P = 0.01)] and chronic liver disease [chronic hepatitis: OR = 2.4 (95% CI = 0.9-6.5, P = 0.07); liver cirrhosis class A: OR = 8.4 (95% CI = 2.8-25.3, P = 0.00); liver cirrhosis class B: OR = 9.38 (95% CI = 0.7-115.5, P = 0.08)]. The most significant perioperative risk factors for postoperative morbidity were high TNM stage and combined organ resection (P < 0.05), and there was no association between increased postoperative morbidity and well controlled hypertension, anticoagulant therapy, diabetes mellitus, pulmonary disease, tuberculosis, or thyroid disease (P > 0.05).

CONCLUSION

Patients with heart disease or chronic liver disease are at a higher risk of morbidity following radical surgery for gastric cancer.

摘要

背景

本研究旨在探讨胃癌根治性手术后(i)合并症和(ii)围手术期危险因素与发病率之间的可能关联。

材料和方法

连续纳入 759 例接受胃癌根治性胃切除术和 D2 水平淋巴结清扫术的患者。前瞻性收集患者特征、手术方法和并发症的临床数据。

结果

根治性胃切除术的发病率为 14.2%(108/759)。术后发病率的显著合并症危险因素是心脏病[抗凝药物:OR=1.5(95%CI=0.35-6.6,P=0.53);无药物史:OR=4.0(95%CI=1.1-14.6,P=0.03);有药物史:OR=6.7(95%CI=1.5-29.9,P=0.01)]和慢性肝病[慢性肝炎:OR=2.4(95%CI=0.9-6.5,P=0.07);A级肝硬化:OR=8.4(95%CI=2.8-25.3,P=0.00);B 级肝硬化:OR=9.38(95%CI=0.7-115.5,P=0.08)]。术后发病率的显著围手术期危险因素是高 TNM 分期和联合器官切除术(P<0.05),而高血压、抗凝治疗、糖尿病、肺部疾病、结核病或甲状腺疾病得到良好控制与术后发病率增加之间无关联(P>0.05)。

结论

心脏病或慢性肝病患者行胃癌根治性手术后发病率较高。

相似文献

1
Increased morbidity rates in patients with heart disease or chronic liver disease following radical gastric surgery.根治性胃手术后心脏病或慢性肝病患者发病率增加。
J Surg Oncol. 2010 Mar 1;101(3):200-4. doi: 10.1002/jso.21467.
2
Postoperative morbidity and mortality after gastrectomy for gastric carcinoma.胃癌胃切除术后的术后发病率和死亡率。
Hepatogastroenterology. 2001 Sep-Oct;48(41):1517-20.
3
[Multivariate logistic regression analysis of postoperative severe complications and discriminant model establishment in gastric cancer post gastrectomy].[胃癌胃切除术后严重并发症的多因素逻辑回归分析及判别模型建立]
Zhonghua Wai Ke Za Zhi. 2008 Dec 15;46(24):1902-5.
4
[Metastasis rates of lymph nodes and distribution in advanced gastric cancer and its clinical significance].[进展期胃癌淋巴结转移率及分布情况及其临床意义]
Zhonghua Wei Chang Wai Ke Za Zhi. 2006 Nov;9(6):506-9.
5
Morbidity and mortality after D1 and D2 gastrectomy for cancer: interim analysis of the Italian Gastric Cancer Study Group (IGCSG) randomised surgical trial.D1和D2胃癌根治术后的发病率和死亡率:意大利胃癌研究组(IGCSG)随机外科试验的中期分析
Eur J Surg Oncol. 2004 Apr;30(3):303-8. doi: 10.1016/j.ejso.2003.11.020.
6
[Morbidity and mortality in gastric cancer surgery--analysis of 468 cases with gastric adenocarcinoma].[胃癌手术的发病率和死亡率——468例胃腺癌病例分析]
Chirurgia (Bucur). 2008 Sep-Oct;103(5):529-37.
7
Resection for gastric cancer in the community.社区胃癌切除术
Semin Oncol. 2005 Dec;32(6 Suppl 9):S90-3. doi: 10.1053/j.seminoncol.2005.06.010.
8
[Risk factors of intra-abdominal infection following gastrectomy in gastric cancer patients].
Zhonghua Wei Chang Wai Ke Za Zhi. 2009 Mar;12(2):137-40.
9
Differential effects of radical D2-lymphadenectomy and splenectomy in surgically treated gastric cancer patients.根治性D2淋巴结清扫术和脾切除术对手术治疗的胃癌患者的不同影响。
Hepatogastroenterology. 2000 Mar-Apr;47(32):579-85.
10
Surgical outcome of 483 patients with early gastric cancer: prognosis, postoperative morbidity and mortality, and gastric remnant cancer.483例早期胃癌患者的手术结果:预后、术后发病率和死亡率以及残胃癌
Hepatogastroenterology. 2004 Jan-Feb;51(55):82-5.

引用本文的文献

1
Intolerability to postoperative early oral nutrition in older patients (≥70 years) undergoing gastrectomy for gastric cancer: A case-control study.老年(≥70 岁)胃癌患者行胃切除术后不耐受早期口服营养:一项病例对照研究。
PLoS One. 2021 May 19;16(5):e0251844. doi: 10.1371/journal.pone.0251844. eCollection 2021.
2
Pancreatic Fistula after D1+/D2 Radical Gastrectomy according to the Updated International Study Group of Pancreatic Surgery Criteria: Risk Factors and Clinical Consequences. Experience of Surgeons with High Caseloads in a Single Surgical Center in Eastern Europe.根据更新后的国际胰腺手术研究组标准,D1+/D2根治性胃切除术后的胰瘘:危险因素与临床后果。东欧单一外科中心高病例量外科医生的经验。
J Gastric Cancer. 2021 Mar;21(1):16-29. doi: 10.5230/jgc.2021.21.e3. Epub 2021 Mar 18.
3
Prediction of Postoperative Mortality in Patients with Organ Failure After Gastric Cancer Surgery.预测胃癌手术后器官衰竭患者的术后死亡率。
World J Surg. 2020 May;44(5):1569-1577. doi: 10.1007/s00268-020-05382-9.
4
Feasibility of Laparoscopic Distal Gastrectomy for Stage I Gastric Cancer in Patients Outside of Clinical Trials.腹腔镜下远端胃癌切除术治疗临床试验以外的Ⅰ期胃癌的可行性。
J Gastrointest Surg. 2018 Oct;22(10):1665-1671. doi: 10.1007/s11605-018-3842-6. Epub 2018 Jun 18.
5
Safety and curability of laparoscopic gastrectomy in elderly patients with gastric cancer.腹腔镜胃癌根治术治疗老年胃癌患者的安全性及根治性。
Surg Endosc. 2018 Oct;32(10):4277-4283. doi: 10.1007/s00464-018-6177-1. Epub 2018 Mar 30.
6
Is it possible to reduce the surgical mortality and morbidity of peptic ulcer perforations?是否有可能降低消化性溃疡穿孔的手术死亡率和发病率?
Turk J Surg. 2017 Dec 1;33(4):267-273. doi: 10.5152/turkjsurg.2017.3670. eCollection 2017.
7
Low forced vital capacity predicts poor prognosis in gastric cancer patients.低用力肺活量预示着胃癌患者预后不良。
Oncotarget. 2017 Apr 25;8(17):28897-28905. doi: 10.18632/oncotarget.15953.
8
Lymphadenectomy: state of the art.淋巴结清扫术:最新进展
Transl Gastroenterol Hepatol. 2017 Jan 17;2:3. doi: 10.21037/tgh.2017.01.01. eCollection 2017.
9
C-reactive protein can be an early predictor of postoperative complications after gastrectomy for gastric cancer.C反应蛋白可以作为胃癌胃切除术后术后并发症的早期预测指标。
Surg Endosc. 2017 Jan;31(1):445-454. doi: 10.1007/s00464-016-5272-4. Epub 2016 Oct 12.
10
Clinical and surgical factors associated with organ/space surgical site infection after laparoscopic gastrectomy for gastric cancer.腹腔镜胃癌根治术后器官/腔隙手术部位感染相关的临床及手术因素
Surg Endosc. 2017 Apr;31(4):1667-1674. doi: 10.1007/s00464-016-5156-7. Epub 2016 Aug 9.